{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:03:24Z","timestamp":1777525404772,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T00:00:00Z","timestamp":1277337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cytopathology"],"published-print":{"date-parts":[[2010,8,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>The Hybrid Capture II high\u2010risk human papillomavirus (hrHPV) DNA test is a US Food and Drug Administration\u2010approved nucleic acid hybridization assay using chemiluminescence for the semiquantitative detection of hrHPV in cervical samples. Patient samples and controls are used to calculate results as negative for hrHPV if &lt;1.0, positive for hrHPV if &gt;2.5, and \u201cequivocal\u201d if between 1.0 and 2.5.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>The authors reported on the cervical histologic results of 209 patients demonstrating \u201cequivocal\u201d results for hrHPV from SurePath (204 patients) or ThinPrep (5 patients) vials, and compared patients in this cohort with atypical squamous cells of undetermined significance (ASC\u2010US) cytology on the index cervical Papanicolaou (Pap) test (Group 1; n = 148 patients) with a patient cohort demonstrating unequivocal positive hrHPV test results (Group 2; n = 148 patients). The chemiluminescence intensity of hrHPV tests from patients in Group 2 were correlated with the presence and severity of dysplasia on subsequent histologic results, and patients were thereby stratified for their subsequent risk of cervical intraepithelial neoplasia (CIN) types II\/III.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Approximately 97% of hrHPV tests demonstrating \u201cequivocal\u201d results were found to be positive at the time of retesting, and 15% of biopsied cases demonstrated CIN II or III. Results of follow\u2010up histology after an ASC\u2010US diagnosis, expressed as a percentage of the biopsied cohort, were: CIN II\/III: 16.5% in Group 1 and 22.4% in Group 2; CIN I: 27% in Group 1 and 23.5% in Group 2; and negative: 56.5% in Group 1 and 54.1% in Group 2. Chemiluminescence intensity did not appear to be correlated with the severity of dysplasia.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>The percentage of high\u2010grade CIN in the \u201cequivocal\u201d hrHPV cohort is highly significant and therefore the management of these patients should be similar to the unequivocally positive population. After an unequivocal positive hrHPV test, the hrHPV chemiluminescence intensity does not appear to further predict the rate of high\u2010grade CIN. Cancer (Cancer Cytopathol) 2010. \u00a9 2010 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncy.20093","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T11:36:44Z","timestamp":1277379404000},"page":"209-217","source":"Crossref","is-referenced-by-count":9,"title":["Correlation between hybrid capture II high\u2010risk human papillomavirus DNA test chemiluminescence intensity from cervical samples with follow\u2010up histologic results"],"prefix":"10.1002","volume":"118","author":[{"given":"Stewart M.","family":"Knoepp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane L.","family":"Kuebler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Wilbur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1845"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1309\/RNF3C01JKADQCLKP"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc798"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120000369"},{"key":"e_1_2_6_7_2","first-page":"4862","article-title":"Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis","volume":"63","author":"Riley RR","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.9.690"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.07.049"},{"issue":"3","key":"e_1_2_6_10_2","first-page":"S3\/164","article-title":"Chapter 19: Cost\u2010effectiveness of cervical cancer screening","volume":"24","author":"Goldie SJ","year":"2006","journal-title":"Vaccine"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of 3 management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon D","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)01922-1"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000120143.50098.c7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.07.050"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21955"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1754"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21161"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22285"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20043"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/PDM.0b013e31805c99ae"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0240"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000325597"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22951"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.03.077"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0799"},{"key":"e_1_2_6_26_2","first-page":"207a","article-title":"A weakly positive HPV Hybrid Capture II result correlates with a significantly lower risk of HSIL following ASC\u2010US cytology","volume":"21","author":"Jarboe EA","year":"2008","journal-title":"Mod Pathol."},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1812"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09463-1"},{"key":"e_1_2_6_29_2","first-page":"1038","article-title":"Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low\u2010grade lesions","volume":"12","author":"Sherman ME","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00896-09"}],"container-title":["Cancer Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncy.20093","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncy.20093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:12:19Z","timestamp":1760299939000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncy.20093"}},"subtitle":["A cytologic\/histologic review of 367 cases"],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8,25]]}},"alternative-id":["10.1002\/cncy.20093"],"URL":"https:\/\/doi.org\/10.1002\/cncy.20093","archive":["Portico"],"relation":{},"ISSN":["1934-662X","1934-6638"],"issn-type":[{"value":"1934-662X","type":"print"},{"value":"1934-6638","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,16]]}}}